| [1] | CHEN W, ZHENG R, BAADE PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2):115. doi: 10.3322/caac.21338 |
| [2] | SHENG X, SUN X, SUN K, et al.Inhibitory effect of bufalin combined with Hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells[J].Int J Oncol, 2016, 49(4):1513. doi: 10.3892/ijo.2016.3667 |
| [3] | YANG T, SHI R, CHANG L, et al.Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF-α/TNFR1 pathway in vitro and in vivo[J].J Exp Clin Cancer Res, 2015, 34(1):21. doi: 10.1186/s13046-015-0134-9 |
| [4] | 于秀荣, 陈钧泽, 李慧杰, 等.华蟾素抗肿瘤研究[J].中医学报, 2019, 34(6):1174. |
| [5] | 熊飞, 施嫣嫣, 沈久成, 等.华蟾素对肺癌NCI-A549移植瘤裸鼠的抑制作用及机制研究[J].中国临床药理学与治疗学, 2018, 23(10):1103. |
| [6] | WANG JY, CHEN L, ZHENG Z, et al.Cinobufocini inhibits NF-kappaB and COX-2 activation induced by TNF-α in lung adenocarcinoma cells[J].Oncol Rep, 2012, 27(5):1619. |
| [7] | FUMAROLA C, BONELLI MA, PETRONINI PG, et al.Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer[J].Biochem Pharmacol, 2014, 90(3):197. doi: 10.1016/j.bcp.2014.05.011 |
| [8] | 葛信艳, 黄玮, 李瑞琴, 等.PI3K/AKt信号转导通路与肿瘤发生相互作用的机制研究[J].中国现代医药杂志, 2017, 19(7):98. |
| [9] | CHANG H, CAI Z, ROBERTS TM.The mechanisms underlying PTEN loss in human tumors suggest potential therapeutic opportunities[J].Biomolecules, 2019, 9(11):713. doi: 10.3390/biom9110713 |
| [10] | YEHIA L, KEEL E, ENG C.The clinical spectrum of PTEN mutations[J].Ann Rev Med, 2019, 71:103. |
| [11] | HO J, BASSI C, STAMBOLIC V.Characterization of nuclear PTEN and its post translational modifications[J].Methods, 2015, 77/78:104. doi: 10.1016/j.ymeth.2015.01.006 |
| [12] | ENGELMAN JA, LUO J, CANTLEY LC.The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism[J].Nat Rev Genet, 2006, 7(8):606. doi: 10.1038/nrg1879 |